Germany Oligonucleotide Synthesis Market Size & Outlook
Global Market
Related Markets
Germany oligonucleotide synthesis market highlights
- The Germany oligonucleotide synthesis market generated a revenue of USD 253.5 million in 2025 and is expected to reach USD 781.0 million by 2033.
- The Germany market is expected to grow at a CAGR of 15.4% from 2026 to 2033.
- In terms of segment, services was the largest revenue generating product in 2025.
- Services is the most lucrative product segment registering the fastest growth during the forecast period.
Oligonucleotide synthesis market data book summary
| Market revenue in 2025 | USD 253.5 million |
| Market revenue in 2033 | USD 781.0 million |
| Growth rate | 15.4% (CAGR from 2026 to 2033) |
| Largest segment | Services |
| Fastest growing segment | Services |
| Historical data | 2021 - 2024 |
| Base year | 2025 |
| Forecast period | 2026 - 2033 |
| Quantitative units | Revenue in USD million |
| Market segmentation | Oligonucleotides, Equipment/Synthesizer, Reagents, Services |
| Key market players worldwide | Thermo Fisher Scientific Inc, Merck KGaA, GE HealthCare Technologies Inc Common Stock, Agilent Technologies, Kaneka Corp, Heritage Global Inc, Twist Bioscience Corp, Bio-Synthesis, Biolegio |
Other key industry trends
- In terms of revenue, Germany accounted for 7.0% of the global oligonucleotide synthesis market in 2025.
- Country-wise, U.S. is expected to lead the global market in terms of revenue in 2033.
- In Europe, Germany oligonucleotide synthesis market is projected to lead the regional market in terms of revenue in 2033.
- UK is the fastest growing regional market in Europe and is projected to reach USD 708.0 million by 2033.
The healthcare system in Germany is considered as strong & sufficiently financed, which is expected to increase the demand for advanced diagnostic and therapeutic technologies, including oligonucleotides. This includes applications in cancer diagnostics, personalized medicine, and gene therapy.
Moreover, Germany’s strong R&D landscape in these areas is expected to improve the adoption of innovative therapies. Germany is one of the global leaders in scientific research, with renowned institutions and multiple biotechnology companies actively developing oligonucleotide-based diagnostics, research tools, and novel therapeutics.
Furthermore, the government in Germany is actively promoting the development of biotechnology and healthcare infrastructure. Initiatives like “Industrie 4.0” and grants for R&D empower domestic players and attract foreign investments, impacting the oligonucleotide market positively.
No credit card required*
Horizon in a snapshot
- 30K+ Global Market Reports
- 120K+ Country Reports
- 1.2M+ Market Statistics
- 200K+ Company Profiles
- Industry insights and more
Three ways to get this data
Subscribe to the databook, customize it, or ask a question.Horizon Databook
Unlock every chart on this page and get dashboard access
- Statistics1.2M+ across all markets
- Databooks30K+ global, 120K+ country
- Companies200K+ profiles
- ExportPDF, Dashboard, XLS & PNG, licensed to cite
Customize it
Customize data as per your requirement
- AddCountries, segments, years
- RecutTo your product definition
- ExtendCompany-level detail
- OrA bespoke databook
- Turnaround5–10 working days
Ask Prism AI
A cited answer in seconds
- Corpus30,000 studies, 1.2M points
- ScopeAll markets, not just this
- CitationTraced to report & table
- HonestySays "not covered" if so
- SpeedSeconds, not days
Oligonucleotide Synthesis Market Scope
Oligonucleotide Synthesis Market Companies
| Name | Profile | # Employees | HQ | Website |
|---|---|---|---|---|
| Merck KGaA | View profile | 62,345 | Frankfurter Strasse 250, Darmstadt, HE, Germany, 64293 | www.emdgroup.com |
| GE HealthCare Technologies Inc Common Stock | View profile | 51,000 | 500 West Monroe Street, Chicago, IL, United States, 60661 | www.gehealthcare.com |
| Thermo Fisher Scientific Inc | View profile | 122,000 | 168 Third Avenue, Waltham, MA, United States, 02451 | www.thermofisher.com |
| Agilent Technologies | View profile | 10001+ | Santa Clara, California, United States, North America | www.agilent.com |
| Kaneka Corp | View profile | 13,284 | 3-2-4, Nakanoshima, Kita-ku, Osaka, Japan, 530-8288 | www.kaneka.co.jp |
| Heritage Global Inc | View profile | 82 | 12625 High Bluff Drive, Suite 305, San Diego, CA, United States, 92130 | www.hginc.com |
| Twist Bioscience Corp | View profile | 919 | 681 Gateway Boulevard, South San Francisco, CA, United States, 94080 | www.twistbioscience.com |
| Bio-Synthesis | View profile | 11-50 | Seminole, Texas, United States, North America | www.biosyn.com |
| Biolegio | View profile | 11-50 | Nijmegen, Gelderland, The Netherlands, Europe | www.biolegio.com |
Germany Oligonucleotide Synthesis Market Outlook
The databook is designed to serve as a comprehensive guide to navigating this sector. The databook focuses on market statistics denoted in the form of revenue and y-o-y growth and CAGR across the globe and regions. A detailed competitive and opportunity analyses related to Oligonucleotide Synthesis Market Outlook will help companies and investors design strategic landscapes.
Services was the largest segment with a revenue share of 43.0% in 2025.
Horizon Databook has segmented the Germany oligonucleotide synthesis market based on oligonucleotides, equipment/synthesizer, reagents, services covering the revenue growth of each sub-segment from 2021 to 2033.
The healthcare system in Germany is considered as strong & sufficiently financed, which is expected to increase the demand for advanced diagnostic and therapeutic technologies, including oligonucleotides. This includes applications in cancer diagnostics, personalized medicine, and gene therapy.
Moreover, Germany’s strong R&D landscape in these areas is expected to improve the adoption of innovative therapies. Germany is one of the global leaders in scientific research, with renowned institutions and multiple biotechnology companies actively developing oligonucleotide-based diagnostics, research tools, and novel therapeutics.
Furthermore, the government in Germany is actively promoting the development of biotechnology and healthcare infrastructure. Initiatives like “Industrie 4.0” and grants for R&D empower domestic players and attract foreign investments, impacting the oligonucleotide market positively.
- Germany Oligonucleotide Synthesis Market Product Outlook (Revenue, USD Million , 2021-2033)
- Oligonucleotides
- Equipment/Synthesizer
- Reagents
- Services
- Germany Oligonucleotide Synthesis Market Application Outlook (Revenue, USD Million , 2021-2033)
- PCR Primers
- PCR Assays and Panels
- Sequencing
- DNA Microarrays
- Fluorescence In Situ Hybridization (FISH)
- Antisense Oligonucleotides
- Other Applications
- Germany Oligonucleotide Synthesis Market End Use Outlook (Revenue, USD Million , 2021-2033)
- Academic Research Institutes
- Diagnostic Laboratories
- Pharmaceutical - Biotechnology Companies
Reasons to subscribe to Oligonucleotide Synthesis Market Outlook databook
- Access to comprehensive data: Horizon Databook provides over 1 million market statistics and 20,000+ reports, offering extensive coverage across various industries and regions.
- Informed decision making: Subscribers gain insights into market trends, customer preferences, and competitor strategies, empowering informed business decisions.
- Cost-Effective solution: It's recognized as the world's most cost-effective market research database, offering high ROI through its vast repository of data and reports.
- Customizable reports: Tailored reports and analytics allow companies to drill down into specific markets, demographics, or product segments, adapting to unique business needs.
- Strategic advantage: By staying updated with the latest market intelligence, companies can stay ahead of competitors, anticipate industry shifts, and capitalize on emerging opportunities.
Target buyers of Oligonucleotide Synthesis Market Outlook databook
- Our clientele includes a mix of Oligonucleotide Synthesis Market Outlook companies, investment firms, advisory firms & academic institutions.
- 30% of our revenue is generated working with investment firms and helping them identify viable opportunity areas.
- Approximately 65% of our revenue is generated working with competitive intelligence & market intelligence teams of market participants (manufacturers, service providers, etc.).
- The rest of the revenue is generated working with academic and research not-for-profit institutes. We do our bit of pro-bono by working with these institutions at subsidized rates.
Horizon Databook provides a detailed overview of country-level data and insights on the Germany Oligonucleotide Synthesis Market Outlook, including forecasts for subscribers. This country databook contains high-level insights into Germany Oligonucleotide Synthesis Market Outlook from 2021 to 2033, including revenue numbers, major trends, and company profiles.
Germany Oligonucleotide Synthesis Market, 2021-2033 (US$M)
Germany oligonucleotide synthesis market statistics, by product, 2021-2033 (US$M)
